The hippocampus in aging and Alzheimer's disease

M. J. De Leon, A. Convit, S. DeSanti, J. Golomb, C. Tarshish, H. Rusinek, Matthew Bobinski, C. Ince, D. C. Miller, H. M. Wisniewski, A. E. George

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The role of imaging in the evaluation of neurodegenerative disorders is summarized. The primary role of imaging is to exclude potentially treatable disorders such as meningioma, extracerebral hematoma. Wernicke's disease, and hypothyroidism. Atrophic changes dominate in the hippocampal region on Alzheimer's disease versus the anterior, frontal, and temporal lobes in Pick's disease. Signal hypointensity in the putamen on T2-weighted spin-echo images favors poorly drug-responsive Parkinson's disease whereas putaminal hyperintensity is observed with Creutzfeld-Jacob, Wilson's, and Leigh's diseases. As our population ages, a thorough understanding of imaging findings in a geriatric population assumes an increasing importance.

Original languageEnglish (US)
Pages (from-to)1-17
Number of pages17
JournalNeuroimaging Clinics of North America
Volume5
Issue number1
StatePublished - 1995
Externally publishedYes

Fingerprint

Hippocampus
Alzheimer Disease
Leigh Disease
Pick Disease of the Brain
Wernicke Encephalopathy
Hepatolenticular Degeneration
Putamen
Frontal Lobe
Meningioma
Temporal Lobe
Hypothyroidism
Geriatrics
Neurodegenerative Diseases
Hematoma
Population
Parkinson Disease
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

De Leon, M. J., Convit, A., DeSanti, S., Golomb, J., Tarshish, C., Rusinek, H., ... George, A. E. (1995). The hippocampus in aging and Alzheimer's disease. Neuroimaging Clinics of North America, 5(1), 1-17.

The hippocampus in aging and Alzheimer's disease. / De Leon, M. J.; Convit, A.; DeSanti, S.; Golomb, J.; Tarshish, C.; Rusinek, H.; Bobinski, Matthew; Ince, C.; Miller, D. C.; Wisniewski, H. M.; George, A. E.

In: Neuroimaging Clinics of North America, Vol. 5, No. 1, 1995, p. 1-17.

Research output: Contribution to journalArticle

De Leon, MJ, Convit, A, DeSanti, S, Golomb, J, Tarshish, C, Rusinek, H, Bobinski, M, Ince, C, Miller, DC, Wisniewski, HM & George, AE 1995, 'The hippocampus in aging and Alzheimer's disease', Neuroimaging Clinics of North America, vol. 5, no. 1, pp. 1-17.
De Leon MJ, Convit A, DeSanti S, Golomb J, Tarshish C, Rusinek H et al. The hippocampus in aging and Alzheimer's disease. Neuroimaging Clinics of North America. 1995;5(1):1-17.
De Leon, M. J. ; Convit, A. ; DeSanti, S. ; Golomb, J. ; Tarshish, C. ; Rusinek, H. ; Bobinski, Matthew ; Ince, C. ; Miller, D. C. ; Wisniewski, H. M. ; George, A. E. / The hippocampus in aging and Alzheimer's disease. In: Neuroimaging Clinics of North America. 1995 ; Vol. 5, No. 1. pp. 1-17.
@article{6c1a8ade833e496698f8c3ae066b516a,
title = "The hippocampus in aging and Alzheimer's disease",
abstract = "The role of imaging in the evaluation of neurodegenerative disorders is summarized. The primary role of imaging is to exclude potentially treatable disorders such as meningioma, extracerebral hematoma. Wernicke's disease, and hypothyroidism. Atrophic changes dominate in the hippocampal region on Alzheimer's disease versus the anterior, frontal, and temporal lobes in Pick's disease. Signal hypointensity in the putamen on T2-weighted spin-echo images favors poorly drug-responsive Parkinson's disease whereas putaminal hyperintensity is observed with Creutzfeld-Jacob, Wilson's, and Leigh's diseases. As our population ages, a thorough understanding of imaging findings in a geriatric population assumes an increasing importance.",
author = "{De Leon}, {M. J.} and A. Convit and S. DeSanti and J. Golomb and C. Tarshish and H. Rusinek and Matthew Bobinski and C. Ince and Miller, {D. C.} and Wisniewski, {H. M.} and George, {A. E.}",
year = "1995",
language = "English (US)",
volume = "5",
pages = "1--17",
journal = "Neuroimaging Clinics of North America",
issn = "1052-5149",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The hippocampus in aging and Alzheimer's disease

AU - De Leon, M. J.

AU - Convit, A.

AU - DeSanti, S.

AU - Golomb, J.

AU - Tarshish, C.

AU - Rusinek, H.

AU - Bobinski, Matthew

AU - Ince, C.

AU - Miller, D. C.

AU - Wisniewski, H. M.

AU - George, A. E.

PY - 1995

Y1 - 1995

N2 - The role of imaging in the evaluation of neurodegenerative disorders is summarized. The primary role of imaging is to exclude potentially treatable disorders such as meningioma, extracerebral hematoma. Wernicke's disease, and hypothyroidism. Atrophic changes dominate in the hippocampal region on Alzheimer's disease versus the anterior, frontal, and temporal lobes in Pick's disease. Signal hypointensity in the putamen on T2-weighted spin-echo images favors poorly drug-responsive Parkinson's disease whereas putaminal hyperintensity is observed with Creutzfeld-Jacob, Wilson's, and Leigh's diseases. As our population ages, a thorough understanding of imaging findings in a geriatric population assumes an increasing importance.

AB - The role of imaging in the evaluation of neurodegenerative disorders is summarized. The primary role of imaging is to exclude potentially treatable disorders such as meningioma, extracerebral hematoma. Wernicke's disease, and hypothyroidism. Atrophic changes dominate in the hippocampal region on Alzheimer's disease versus the anterior, frontal, and temporal lobes in Pick's disease. Signal hypointensity in the putamen on T2-weighted spin-echo images favors poorly drug-responsive Parkinson's disease whereas putaminal hyperintensity is observed with Creutzfeld-Jacob, Wilson's, and Leigh's diseases. As our population ages, a thorough understanding of imaging findings in a geriatric population assumes an increasing importance.

UR - http://www.scopus.com/inward/record.url?scp=0028938820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028938820&partnerID=8YFLogxK

M3 - Article

C2 - 7743078

AN - SCOPUS:0028938820

VL - 5

SP - 1

EP - 17

JO - Neuroimaging Clinics of North America

JF - Neuroimaging Clinics of North America

SN - 1052-5149

IS - 1

ER -